The 18th BGICC Breast & Gynecological International Cancer Conference (BGICC 2026) is taking place today, January 22, 2026, in Cairo, Egypt. As a distinguished international platform, BGICC brings together leading oncology experts to foster multidisciplinary collaboration, evidence-based discussions, and innovation in cancer care.
With the participation of global leaders, including Dr. Lynn, ASCO Past President, this year’s conference continues BGICC’s mission of translating scientific advances into clinical practice and improving patient outcomes worldwide.
American Society for Radiation Oncology (ASTRO):
“More from ASTRO at hashtag#BGIICC in Cairo! Former ASTRO President Thomas Eichler with Dr. Hesham El-Ghazaly, BGIICC founder and meeting host, and the Egyptian Cancer Society ECS leadership.”
“Such a special BGIICC faculty dinner at the National Museum of Egyptian Civilization. Breast, Gynecological, and Immunooncology International Cancer Conference in Cairo.”
“Honored to give keynote in session on precision oncology at BGIICC in Cairo.”
“Attending the 18th Breast Gynecological & Immunooncology International Cancer Conference-BGICC where Cancer Leaders & organisations across the Globe gather in Egypt!
Featuring a high impact strategic collaboration with MSD advancing women’s cancers across policy and clinical care.
Policy: Showcasing the Egyptian Presidential Breast Cancer initiatives as a population-level model aligned with WHO benchmarks, following the congress opening in the presence of H.E. Prof. Khaled Abdel Ghaffar, Minister of Health.
Science → Better Patient Care: High-impact Breast & gynecologic oncology sessions with distinguished faculty from Italy, UAE, and Egypt, translating evidence into actionable MDT-driven care.
Proud to contribute for the 2nd year alongside an outstanding team accross the region to meaningful progress in women’s oncology across the region.”
“Terrific session at hashtag#BGIICC on AI in Healthcare in Cairo, Egypt. Moderated by Denis Horgan, Ph.D.
Issues discussed included platforms, endpoints for payers, bias, standardization & certification, resources in LMIC, misinformation, importance for users, i.e. physicians to have a voice to avoid issues and lessons learned with EHR’s, need for aligning training with AI innovation, need to accelerate diagnosis, e.g. of cervical cancer prelesions. Issues were raised about governance structures in AI implementation & international guidance.
I appreciated report by Dr. Julie Gralow about the American Society of Clinical Oncology (ASCO) AI Taskforce for ethical use. ASCO has identified 6 important areas that she discussed:
1- Transparency: how models are trained, inclusion of different populations such as in Africa that is relevant today,
2- Need to inform stakeholders: patients & clinicians need to know how AI is being used for example in insurance denials & emerging strategies for its use in appeals,
3- Equity/fairness: by example ensuring that algorithms do not bias against patients who did not show up to a clinic appointment because they were seen in the ER and another appointment was scheduled,
4- Accountability: Legal, regulatory, ethics. Healthcare providers need to be involved.
5- Patient privacy: Patients need to be aware that the questions they ask Chat-GPT are in the cloud.
6- Human-centered applications. Human involvement is a fundamental element of care. She spoke of strategies for having accurate evidence-based information in AI algorithms. She gave examples of use of AI to improve screening such as colonoscopies with appointments scheduled after AI discusses with patients.
The charge from Dr. Hesham ElGhazaly was to provide outcomes highlighting priority themes and coordination mechanisms.
My suggestions were:
1- Need to address data sources used for training AI with attention to the diversity within populations and the known issue of data aggregation.
2- Research is very important. I mentioned the WIN Consortium in cancer personalized medicine data science committee chaired by Dr. Gerald Batist and Dr. Yves Lussier that has been meeting for a couple of years. Challenges were identified with data interoperability, & opportunities for international collaboration, e.g. therapeutic outcomes across globe with targeting DNA repair /PARP inhibitors, immunotherapy among others.
3- There is need for prospective validation research.
4- I discussed concept WIN has developed >2 yrs ago in collaboration with Caris Life Sciences & Dr. David Spetzler that we refer to as the AI-EE (artificial intelligence for enrichment and equity) trial. This uses AI algorithms & digital pathology images to enrich for driver mutations for which there are therapeutics. Discussions of implementation are ongoing including discussions with pharma.
5- Cautionary note: Be aware with AI of slippery slope to save money. Very important.”
“Limited free spots are available for the largest oncology conference in the MENA Region and Egypt (BGICC at its 18th edition).
This year BGICC features with combining large three conferences (BGICC, ICLC, and) Onco Bronco
It will be held 22,23 Jan at Cairo Helio, thanks for all responsible for organizing the conference.Hesham ElGhazaly Prof. Ola Khorshid MD PhD Ahmed Magdy Rabea Heba Bakri David Carbone Giuseppe Curigliano fabrice andre Wafik S. El-Deiry, MD, PhD, FACP
My pleasure would to meet you there, whilst time constraints exist.
Emad Shash Loay Kassem Hend M. El Tayebi, PhD, MSc, MBA, BCPS hebatallah Masoud M.Sc Mahmoud El Nasharty Seif Ismail Yasein Fadel Awadalla Mostafa Khalifa
Registration Link
https://lnkd.in/dDaaqih4
This is Ahmed Bahr, the former head of the ASSIA Research Team, Top 1 cancer creator on LinkedIn in Africa, transforming LinkedIn users mindset and profiles, and a third-year medical student at the Faculty of Medicine, Alexandria University.”
Wafik S. El-Deiry, MD, PhD, FACP:
“Enjoyable group dinner event at the National Museum of Egyptian Civilization in Old Cairo during the 18th BGIICC 2026 meeting. Appreciate time spent with ASCO
leaders including Charles Balch, Lynn Schuchter, and Julie Gralow . Great to see Amal Al Omari from King Hussein Cancer Foundation and Center. ”
“with Dr. Lynn M. Schuchter Former President of American Society of Clinical Oncology (ASCO)”
“I would like to sincerely thank my dear Professors Hesham ElGhazaly , Ahmed Magdy Rabea Dina Salem for their tremendous efforts in organizing such an outstanding program with excellent speakers
I am honored to have the opportunity to discuss cases during the Molecular/ Pathology integrated sloutions session on Friday at 10:20 AM with such a distinguished panel
Looking forward to a great scientific exchange and learning experience.”
“After a 24 exciting hour trip to BGIIC in Cairo flying back home to resume our top priority and mission: treating & supporting our cancer patients.
Arrived home at 1:30 AM.
Morning rounds with our team at 7:30 AM.”
More posts about BGICC on OncoDaily
Written by Nare Hovhannisyan, MD